☰

Devki Sukhtankar, Ph.D. - Publications

Affiliations: 
2011 Cancer Biology University of Arizona, Tucson, AZ 
Area:
pain, opioids, pharmacology
Tree Info Grants Similar researchers PubMed Report error

8/18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Havelin J, Imbert I, Sukhtankar D, Remeniuk B, Pelletier I, Gentry J, Okun A, Tiutan T, Porreca F, King T. Mediation of movement-induced breakthrough cancer pain by IB4 binding nociceptors in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28438966 DOI: 10.1523/Jneurosci.1212-16.2017  0.662
2015 Remeniuk B, Sukhtankar D, Okun A, Navratilova E, Xie JY, King T, Porreca F. Behavioral and Neurochemical Analysis of Ongoing Bone Cancer Pain in Rats. Pain. PMID 25955964 DOI: 10.1097/J.Pain.0000000000000218  0.605
2015 Ding H, Hayashida K, Suto T, Sukhtankar DD, Kimura M, Mendenhall V, Ko MC. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates. British Journal of Pharmacology. 172: 3302-12. PMID 25752320 DOI: 10.1111/bph.13124  0.44
2014 Sukhtankar DD, Lee H, Rice KC, Ko MC. Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain Psychopharmacology. 231: 1377-1387. PMID 24217900 DOI: 10.1007/S00213-013-3341-0  0.556
2013 Sukhtankar DD, Zaveri NT, Husbands SM, Ko MC. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain. The Journal of Pharmacology and Experimental Therapeutics. 346: 11-22. PMID 23652222 DOI: 10.1124/jpet.113.203984  0.306
2013 Sukhtankar D, Ko MC. Pharmacological investigation of NOP-related ligands as analgesics without abuse liability Acs Symposium Series. 1131: 393-416. DOI: 10.1021/bk-2013-1131.ch018  0.392
2011 Sukhtankar D, Okun A, Chandramouli A, Nelson MA, Vanderah TW, Cress AE, Porreca F, King T. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Molecular Pain. 7: 81. PMID 22014040 DOI: 10.1186/1744-8069-7-81  0.614
2011 Ondoua A, Hanlon K, Largent-Milnes T, Sukhtankar D, King T, Mantyh P, Vanderah T. CB2 receptor agonists act as a disease-modifying treatment by attenuating breast cancer-induced bone pain and improving bone health in a murine model of breast cancer metastases The Journal of Pain. 12: P51. DOI: 10.1016/J.Jpain.2011.02.207  0.666
Low-probability matches (unlikely to be authored by this person)
2015 Rizzi A, Sukhtankar DD, Ding H, Hayashida K, Ruzza C, Guerrini R, Calò G, Ko MC. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys. British Journal of Pharmacology. 172: 3661-70. PMID 25828800 DOI: 10.1111/bph.13150  0.271
2013 Sukhtankar DD, Ko MC. Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. Plos One. 8: e67422. PMID 23826298 DOI: 10.1371/journal.pone.0067422  0.193
2019 Kiguchi N, Ding H, Cami-Kobeci G, Sukhtankar DD, Czoty PW, DeLoid HB, Hsu FC, Toll L, Husbands SM, Ko MC. BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates. British Journal of Anaesthesia. PMID 30916003 DOI: 10.1016/J.Bja.2018.10.065  0.191
2016 Ding H, Czoty PW, Kiguchi N, Cami-Kobeci G, Sukhtankar DD, Nader MA, Husbands SM, Ko MC. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates. Proceedings of the National Academy of Sciences of the United States of America. PMID 27573832 DOI: 10.1073/Pnas.1605295113  0.175
2014 Sukhtankar DD, Lagorio CH, Ko MC. Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats. European Journal of Pharmacology. 745: 182-9. PMID 25446568 DOI: 10.1016/J.Ejphar.2014.10.029  0.171
2015 Kiguchi N, Sukhtankar DD, Ding H, Tanaka KI, Kishioka S, Peters CM, Ko MC. Spinal functions of B-type natriuretic peptide, gastrin-releasing peptide, and their cognate receptors for regulating itch in mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 26669425 DOI: 10.1124/jpet.115.229997  0.12
2015 Rizzi A, Sukhtankar DD, Ding H, Hayashida K, Ruzza C, Guerrini R, Calò G, Ko MC. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys British Journal of Pharmacology. 172: 3661-3670. DOI: 10.1111/bph.13150  0.12
2023 Sukhtankar DD, Chang LW, Tsai CY, Cardarelli PM, Caculitan NG. Pharmacokinetics and Pharmacodynamics of Burixafor Hydrobromide (GPC-100), a Novel C-X-C Chemokine Receptor 4 Antagonist and Mobilizer of Hematopoietic Stem/Progenitor Cells, in Mice and Healthy Subjects. Clinical Pharmacology in Drug Development. PMID 37539772 DOI: 10.1002/cpdd.1302  0.089
2023 Sukhtankar DD, Fung JJ, Kim MN, Cayton T, Chiou V, Caculitan NG, Zalicki P, Kim S, Jo Y, Kim S, Lee JM, Choi J, Mun S, Chin A, Jang Y, et al. GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol. Plos One. 18: e0287863. PMID 37878624 DOI: 10.1371/journal.pone.0287863  0.083
1986 Patel SK, Sukhtankar DR. URBAN DISTRIBUTION SYSTEM PROTECTION Electrical India. 26: 5-12.  0.01
Hide low-probability matches.